| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373312A1 Shellfish protein |
| 01/02/2004 | EP1373311A2 Method for improving plant tolerance to environmental stress |
| 01/02/2004 | EP1373310A2 Staphylococcus aureus proteins and nucleic acids |
| 01/02/2004 | EP1373309A2 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373303A1 Novel peptide ligands of leukocyte integrins |
| 01/02/2004 | EP1373301A2 Reducing the immunogenicity of fusion proteins |
| 01/02/2004 | EP1373297A2 A lac operator-repressor system |
| 01/02/2004 | EP1373295A2 Regulatable growth of filamentous fungi |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1373292A2 Cell cycle nucleic acids, polypeptides and uses thereof |
| 01/02/2004 | EP1373291A2 Antisense modulation of recql4 expression |
| 01/02/2004 | EP1373290A1 Pesticidal spinosyn derivatives |
| 01/02/2004 | EP1372721A2 Method to screen peptide display libraries using minicell display |
| 01/02/2004 | EP1372720A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 01/02/2004 | EP1372718A2 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 01/02/2004 | EP1372711A2 Compositions and methods comprising west nile virus polypeptides |
| 01/02/2004 | EP1372710A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 01/02/2004 | EP1372704A1 Monocyte-specific particulate delivery vehicle |
| 01/02/2004 | EP1372701A2 Methods of therapy for hiv infection |
| 01/02/2004 | EP1372696A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/02/2004 | EP1372691A2 Mucin peptide with immunoenhancing properties |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP1372528A2 Mucosal boosting following parenteral priming |
| 01/02/2004 | EP1372418A2 Non-oligomerizing tandem fluorescent proteins |
| 01/02/2004 | EP1185698A4 Automated nucleic acid compaction device |
| 01/02/2004 | EP1124637B1 Multi-well microfiltration apparatus |
| 01/02/2004 | EP1015495B1 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine |
| 01/02/2004 | EP0910623B1 Thrombin receptor modified transgenic animals |
| 01/02/2004 | EP0871750B1 Removal of metals from contaminated substrates by plants |
| 01/02/2004 | EP0858597B1 Transistor-based apparatus and method for molecular detection |
| 01/02/2004 | EP0831921B1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 01/02/2004 | EP0746343B1 Bioartificial kidney devices coated with cells suitable for use in vivo or ex vivo |
| 01/02/2004 | EP0719343B1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 01/02/2004 | EP0663008B1 Improvements in or relating to immune response modification |
| 01/02/2004 | EP0506780B2 Stable integration of dna in bacterial genomes |
| 01/01/2004 | US20040003435 Nucleotide sequences of interest flanked by non-identical recombination sites (effected by a recombinase) are used to transform a plant containing a target site |
| 01/01/2004 | US20040003434 Agitating a solution containing a germinating plant seedling, or explant, an an agrobacterium strain that harbors a plasmid vector carrying a desired polynucleotide, cultivating the seedling to produce a plant |
| 01/01/2004 | US20040003433 Cell cycle nucleic acids, polypeptides and uses thereof |
| 01/01/2004 | US20040003432 Production of hexosamines and uses thereof |
| 01/01/2004 | US20040003431 Genes coding for flavone synthases |
| 01/01/2004 | US20040003430 Genome contains a transgene that encodes a chimeric ketolase enzyme polypeptide having two portions, an N-terminal portion containing plastid transit peptide portion fused to a second ketolase enzyme portion |
| 01/01/2004 | US20040003429 Coding sequence encodes an amidase, mixed oxidase/cytochrome p450 or esterase enzymes to convert proinsecticide into an active metabolite |
| 01/01/2004 | US20040003428 A polynucleotide having a nucleotide sequence encoding amino acid sequence from methionine at position 1 to serine at position 361 of preferred amino acid or sequence having one or more amino acid deletion, insertion or substitution |
| 01/01/2004 | US20040003427 Novel basal endosperm transfer cell layer (BELT) specific genes |
| 01/01/2004 | US20040003425 Nav2 channel gene-deficient non-human animals |
| 01/01/2004 | US20040003423 Transgenic knockout animal model null for pigment epithelium-derived factor (PEDF) |
| 01/01/2004 | US20040003422 An expression cassette containing the proopiomelanocortin (POMC) enhancer, and a nucleic acid sequence encoding POMC contains at least one exon, wherein a polylinker having an unique site for restriction enzyme is inserted into the exon; gene regulates weight and fat mass |
| 01/01/2004 | US20040003421 Lysosomal proteins produced in the milk of transgenic animals |
| 01/01/2004 | US20040003420 A fusion protein containing a recombinase domain consists of a recombinase protein or a mutant having a recombinase activity similar to wild type recombinase, and a signal peptide domain linked to such recombinase domain |
| 01/01/2004 | US20040003419 Novel taste receptors in Drosophila |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040003417 Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
| 01/01/2004 | US20040002595 Nucleic acid labeling compounds |
| 01/01/2004 | US20040002585 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040002584 Proteins, polynucleotides encoding them and methods of using the same |
| 01/01/2004 | US20040002473 Pain modulation; incotinence therapy; central nervous system disorders |
| 01/01/2004 | US20040002468 Methods of treating diabetes and other blood sugar disorders |
| 01/01/2004 | US20040002467 Antisense modulation of ADAM12 expression |
| 01/01/2004 | US20040002466 Releasing interferon from complex of interferon and nucleic acids; antitumor agents, viricide, induction immunology response |
| 01/01/2004 | US20040002465 Fungicides, parasiticides, antiprotozoa agents; binding antibiotic to nucleic acid |
| 01/01/2004 | US20040002460 Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, and treatments and animal models produced therefrom |
| 01/01/2004 | US20040002459 Nucleic acids encoding kringle 1-5 region fragments of plasminogen |
| 01/01/2004 | US20040002458 Pharmaceutical compositions and methods using natriuretic peptides |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002446 Central nervous system disorders; brain disorders; administering genetic engineered thrombomodulin |
| 01/01/2004 | US20040002440 Modulation gene expression; binding antigen to polypeptide; therapy for infection |
| 01/01/2004 | US20040002439 Human voltage gated sodium channel beta1A subunit and methods of use |
| 01/01/2004 | US20040002431 Polypeptide; laundering detergent |
| 01/01/2004 | US20040002159 Methods for the production of chimeric adeno-associated virus (AAV) vectors, compositions of chimeric AAV vectors, and methods of use thereof |
| 01/01/2004 | US20040002158 Long term expression of lentiviral vectors |
| 01/01/2004 | US20040002157 Novel retroviral constructs |
| 01/01/2004 | US20040002156 Selective cloning of homoduplex nucleic acids |
| 01/01/2004 | US20040002155 A strain of host cells that contains a temperature sensitive variant of the gene encoding the endonuclease VII from phage T4; a cloning method that selects for PCR products that are devoid of PCR-generated mutations |
| 01/01/2004 | US20040002154 Methods for preparing libraries of unique tags and related screening methods |
| 01/01/2004 | US20040002153 Modulation of PTEN expression via oligomeric compounds |
| 01/01/2004 | US20040002152 Oligonucleotides specifically hybridizable with nucleic acids encoding P2X4; P2X4 is a subfamily of the purinoreceptors that are ligand-gated ion channels that respond to the endogenous occurring neurotransmitter Adenosine Triphosphate |
| 01/01/2004 | US20040002151 Antisense modulation of selenophosphate synthetase 2 expression |
| 01/01/2004 | US20040002150 Antisense modulation of hypothetical protein LOC51249 expression |
| 01/01/2004 | US20040002149 Control of the ratio of LAP to LIP |
| 01/01/2004 | US20040002148 Lux expression in eukaryotic cells |
| 01/01/2004 | US20040002144 Extrapolating the structure-binding site by replacing, inserting or deleting amino acids; x-ray crystal structure analysis; streptoverticillium mobaraense |
| 01/01/2004 | US20040002143 Introducing a mutation in a promoter sequence of biosynthesizing genes on a chromosome of coryneform bacterium to make it close to a consensus sequence; high yields |
| 01/01/2004 | US20040002142 Glucoamylase variants |
| 01/01/2004 | US20040002141 Methods and compositions for propagating vectors containing toxic cDNAs and ion channel assay systems |
| 01/01/2004 | US20040002139 Methods for making recombinant proteins using apoptosis inhibitors |
| 01/01/2004 | US20040002138 Alpha,2,8-sialyltransferase |
| 01/01/2004 | US20040002136 Mutant Chrysosporium strain comprising a nucleic acid sequence encoding a polypeptide; expressing and secreting heterologous proteins |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002133 Novel compounds |
| 01/01/2004 | US20040002127 Expression vector containing the polynucleotide; cell transformation; use in diganostics and as substrate for luminescent reactions; coelenterazine |
| 01/01/2004 | US20040002123 Detection of transmembrane potentials by optical methods |
| 01/01/2004 | US20040002122 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/01/2004 | US20040002120 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/01/2004 | US20040002115 Method of identifying protein CAMs (constitutively active mutants) |
| 01/01/2004 | US20040002114 Nucleic acids encoding a G-protein coupled receptor involved in islet cell signaling |